Biotechnology company Moderna, in association with The National Institute of Allergy and Infectious Diseases, has kicked off a Phase 1 human trial testing three different mRNA vaccine formulations ...
A new class of high-power, three-phase AC-DC units with flexible outputs and industrial temp resilience aims to streamline ...
Lupus Therapeutics announced the start of a collaboration to conduct three Phase 3 clinical trials testing an investigational therapeutic ianalumab for systemic lupus erythematosus and lupus nephritis ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback